# Horizon Therapeutics USA, Inc. – FDA Inspection, May 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/horizon-therapeutics-usa-inc/234127af-3893-4edd-9682-b97f2e8c7bea
Source feed: FDA_Inspections

> FDA inspection 1209517 of Horizon Therapeutics USA, Inc., May 25, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209517
- Company Name: Horizon Therapeutics USA, Inc.
- Inspection Date: 2023-05-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- Issuing Officer
- [Company Rep](https://www.keypedia.com/people/jeanne-j-thai/f7b057a4-ab4c-43de-a448-384ff9f8598f)

Company: https://www.keypedia.com/companies/horizon-therapeutics-usa-inc/59538819-cd75-4621-b630-681f24563923

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c